MarketPeel
Insider Trading Intelligence
AS

Aharon Schwartz

PLX
DIRECTOR · PROTALIX BIOTHERAPEUTICS, INC. · CIK 0001625184
FILING MIX · LIFETIME100%/0%
BUYS
8
SELLS
0
TOTAL VALUE
$517.0K
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
7,500
AVG SELL PX
TRADE KIND
SHOWING 8 / 8
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 1 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Aharon Schwartz, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+66.67%+15.92%+2.89%+13.03%+10.58%
14d3+66.67%+25.31%+2.68%+22.62%+16.72%
30d3+66.67%+13.80%+7.24%+6.56%+9.54%
60d3+66.67%+32.23%+10.75%+21.48%+29.14%
90d3+66.67%+37.94%+12.01%+25.93%+32.38%
180d3+100.00%+35.23%+20.00%+15.23%+16.89%
1y3+100.00%+56.71%+34.34%+22.38%+5.68%
2y3(1 pending)+50.00%+1.27%+66.05%-64.78%-64.78%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PLX · 7,500 shares · as of Sep 3, 2025
075,750151,500227,250303,00020212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
FLOW · 8 buys / 0 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Sep 3, 2025Sep 4, 2025View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
7,5007,500Sep 3, 2025Sep 4, 2025View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASE
129,000$1.60$205.9K303,000Jun 10, 2025Aug 12, 2025View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
61,67661,676Sep 29, 2023Oct 3, 2023View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASE
110,000$1.42$155.8K174,000Jan 3, 2023Jan 5, 2023View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
50,00050,000Sep 7, 2022Sep 9, 2022View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASE
64,000$2.43$155.3K64,000Apr 7, 2020Apr 13, 2020View →
PLX
PROTALIX BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
40,00040,000Jan 20, 2020Jan 22, 2020View →
Other insiders · PLX
Loading peer insiders…
About this filer
CIK 0001625184
ROLE
Director
PRIMARY
PLX
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001625184DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback